The muscle findings in the neuroleptic malignant syndrome associated with lysergic acid diethylamide.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1940949.
- Also identified by PMC identifier 1014484.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A detailed pathological description of the muscle findings in a case of the neuroleptic malignant syndrome (NMS) following ingestion of lysergic acid diethylamide (LSD) is given, including the first ultrastructural analysis. Focal necrosis, oedema, and hypercontraction of fibres with glycogen and lipid depletion, were identified, all of which had resolved completely a year later. The findings are compared with those in malignant hyperthermia. It is suggested that the results support the view that in NMS, the muscle rigidity is due to central mechanisms and, in both this disorder and malignant hyperthermia, it is responsible for the hyperpyrexia and its life-threatening complications.
Medical subject headings
- Lysergic Acid Diethylamide
- Muscles
- Neuroleptic Malignant Syndrome